The FMS‐like tyrosine kinase 3 (FLT3) domain is the most mutated gene in acute myeloid leukemia (AML), with FLT3 internal tandem duplication (ITD) mutations conferring adverse outcomes [1, 2]. The gene discussed is FLT3; the disease is acute myeloid leukemia.